Finance entity
markets accounts for 11 of the 13 tracked stories, while 1 other category carries the remainder. Sentiment skews less negative than the wider beat, at 0% negative against 26% across all 4661 Finance stories in the same window. The 5 average consequence score is below the beat benchmark of 6.2 in the same window.
Last mentioned: 5d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets accounts for 11 of the 13 tracked stories, while 1 other category carries the remainder. Sentiment skews less negative than the wider beat, at 0% negative against 26% across all 4661 Finance stories in the same window. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Of the tracked stories, 6 of 13 also mention Weiss Ratings, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window. Across a 217-day span, the pace is roughly 0.4 stories per week. The busiest single day carried 2. This profile follows 13 Finance stories mentioning Wells Fargo & Company across the period from February 21, 2026 to September 25, 2026.
Computed from the 13 stories linked to this entity, with beat comparisons drawn from all 4661 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Wells Fargo & Company. Shared-story counts are live from our verified record — not editorial picks.
Dividend Payment Date
Quarterly dividend paid to shareholders of record July 24.
Wall Street Zen cuts STAG and ZVIA to Sell
Wall Street Zen downgraded both Stag Industrial and Zevia PBC from hold to sell in weekend research notes.
ZVIA reports Q2 results
Zevia PBC reported EPS of -$0.03, hitting consensus, and revenue of $45.00 million versus a $44.21 million estimate.
Weiss reiterates buy on STAG; Baird sets $138 target
Weiss Ratings reiterated a buy (b-) rating on Stag Industrial, while Robert W. Baird set a $138.00 target price.
STAG reports Q2 earnings miss
Stag Industrial reported EPS of $0.28, missing the consensus estimate of $0.65 by $0.37; revenue was approximately $224 million.
Dividend Record Date
Shareholders of record qualify for $0.77 quarterly dividend.
Q2 Earnings Release
Kaiser Aluminum reports EPS $5.53, beats estimates by $2.87; revenue $1.26B surpasses $1.12B estimate.
Weiss Ratings upgrades ZVIA within sell range
Weiss Ratings raised shares of Zevia PBC from a sell (e+) rating to a sell (d-) rating.
Barclays raises STAG target but stays Underweight
Barclays boosted its price objective on Stag Industrial from $38.00 to $41.00 and maintained an underweight rating.
Wells Fargo Reaffirms Underweight
Wells Fargo reiterates underweight rating, sets $158 price target.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
UBS Lifts Price Target
UBS raises Kaiser Aluminum target to $179 from $176, maintains neutral rating.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
Wells Fargo cuts STAG target to $40
Wells Fargo & Company lowered its target price on Stag Industrial from $41.00 to $40.00 and set an equal weight rating.
Caisse sells 2.15M ZVIA shares
Major shareholder Caisse de dépôt et placement du Québec sold 2,150,000 shares of Zevia PBC at an average price of $1.90, totaling $4.085 million, reducing its stake by 15.87%.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
CEO Keith Harvey Sells Shares
Harvey sold 3,031 shares at $173.13, reducing his stake by 3.11% for a total value of $524,757.
Evercore reiterates Outperform on STAG
Evercore reissued an outperform rating and set a $44.00 price objective on Stag Industrial.
Wall Street Zen upgraded CVS Health to strong-buy, adding to 22 buy ratings and a $107.24 consensus target that implies 23% upside from Friday's $87.02 open. Macy's and NewJersey Resources were also upgraded, signaling broad analyst optimism.
Source: dailypolitical.com · themarketsdaily.com
Needham & Company reiterated Buy ratings on Salesforce (CRM) and Solaris Energy Infrastructure (SEI) with price targets of $400 and $98. CRM opened at $259.39, implying 54% upside, while SEI opened at $55.08, implying 78% upside. The ratings highlight divergent risk-reward profiles across software and energy infrastructure.
Source: tickerreport.com · dailypolitical.com
Wall Street Zen cut Stag Industrial to sell, putting a fresh bearish tilt on a REIT whose shares opened at $36.68 versus a $50.50 consensus target. The same firm also downgraded Zevia PBC as its major shareholder trimmed a 15.87% stake.
Source: tickerreport.com · dailypolitical.com
SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Source: tickerreport.com · dailypolitical.com
Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Source: dailypolitical.com · themarketsdaily.com
HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Source: Bbns · Markets Daily
Kaiser Aluminum's Q2 2026 EPS of $5.53 blasts past estimates by 108%, with revenue reaching $1.26B. Despite the beat, the stock slipped 0.03% to $164.32 amid insider sales and mixed analyst targets. The $0.77 quarterly dividend and strong liquidity ratios offer some reassurance.
Source: MarketBeat · themarketsdaily.com
Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition.
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Source: Watch List News · Ticker Report
Raleigh Capital Management increased its Verizon position by a third in Q1 2026, joining other small institutional buyers. Despite VZ's recent price weakness and mixed analyst views, the defensive telecom's high dividend yield and 62% institutional ownership remain draws for income-focused portfolios.
Source: Ticker Report · Daily Political
Wells Fargo has lowered its rating on O-I Glass (NYSE: OI) from Overweight to Equal Weight, signaling a more cautious stance on the glass packaging giant. The move reflects broader industry challenges and a shift in analyst expectations regarding the company's near-term growth trajectory.
Source: tickerreport.com · dailypolitical.com
AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.
Wells Fargo & Company is linked from 13 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
